These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 25793728)

  • 1. Modest attenuation of HIV-1 Vpu alleles derived from elite controller plasma.
    Chen J; Tibroni N; Sauter D; Galaski J; Miura T; Alter G; Mueller B; Haller C; Walker BD; Kirchhoff F; Brumme ZL; Ueno T; Fackler OT
    PLoS One; 2015; 10(3):e0120434. PubMed ID: 25793728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly Sites.
    Pujol FM; Laketa V; Schmidt F; Mukenhirn M; Müller B; Boulant S; Grimm D; Keppler OT; Fackler OT
    J Virol; 2016 Aug; 90(15):6709-6723. PubMed ID: 27170757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minor contribution of HLA class I-associated selective pressure to the variability of HIV-1 accessory protein Vpu.
    Hasan Z; Carlson JM; Gatanaga H; Le AQ; Brumme CJ; Oka S; Brumme ZL; Ueno T
    Biochem Biophys Res Commun; 2012 May; 421(2):291-5. PubMed ID: 22503975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell Surface Downregulation of NK Cell Ligands by Patient-Derived HIV-1 Vpu and Nef Alleles.
    Galaski J; Ahmad F; Tibroni N; Pujol FM; Müller B; Schmidt RE; Fackler OT
    J Acquir Immune Defic Syndr; 2016 May; 72(1):1-10. PubMed ID: 26656785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Vpu's lipid raft association is dispensable for counteraction of the particle release restriction imposed by CD317/Tetherin.
    Fritz JV; Tibroni N; Keppler OT; Fackler OT
    Virology; 2012 Mar; 424(1):33-44. PubMed ID: 22222210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional conservation and coherence of HIV-1 subtype A Vpu alleles.
    Romani B; Kavyanifard A; Allahbakhshi E
    Sci Rep; 2017 Dec; 7(1):87. PubMed ID: 28273896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of tetherin and CD4 counter-activities in circulating Vpu alleles despite extensive sequence variation within HIV-1 infected individuals.
    Pickering S; Hué S; Kim EY; Reddy S; Wolinsky SM; Neil SJ
    PLoS Pathog; 2014 Jan; 10(1):e1003895. PubMed ID: 24465210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vpu-mediated CD4 down-regulation and degradation is conserved among highly divergent SIV(cpz) strains.
    Gomez LM; Pacyniak E; Flick M; Hout DR; Gomez ML; Nerrienet E; Ayouba A; Santiago ML; Hahn BH; Stephens EB
    Virology; 2005 Apr; 335(1):46-60. PubMed ID: 15823605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidences for viral strain selection in late stages of HIV infection: an analysis of Vpu alleles.
    Gondim MV; da Silva JX; Prosdocimi F; Leonardecz-Neto E; Franco OL; Argañaraz ER
    Protein J; 2012 Feb; 31(2):184-93. PubMed ID: 22237729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polarity changes in the transmembrane domain core of HIV-1 Vpu inhibits its anti-tetherin activity.
    Lv M; Wang J; Wang X; Zuo T; Zhu Y; Kong W; Yu X
    PLoS One; 2011; 6(6):e20890. PubMed ID: 21674066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV Vpu Interferes with NF-κB Activity but Not with Interferon Regulatory Factor 3.
    Manganaro L; de Castro E; Maestre AM; Olivieri K; García-Sastre A; Fernandez-Sesma A; Simon V
    J Virol; 2015 Oct; 89(19):9781-90. PubMed ID: 26178989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human-Specific Adaptations in Vpu Conferring Anti-tetherin Activity Are Critical for Efficient Early HIV-1 Replication In Vivo.
    Yamada E; Nakaoka S; Klein L; Reith E; Langer S; Hopfensperger K; Iwami S; Schreiber G; Kirchhoff F; Koyanagi Y; Sauter D; Sato K
    Cell Host Microbe; 2018 Jan; 23(1):110-120.e7. PubMed ID: 29324226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Vpu mediated downregulation of CD155 requires alanine residues 10, 14 and 18 of the transmembrane domain.
    Bolduan S; Reif T; Schindler M; Schubert U
    Virology; 2014 Sep; 464-465():375-384. PubMed ID: 25113908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convergent Evolution of HLA-C Downmodulation in HIV-1 and HIV-2.
    Hopfensperger K; Richard J; Stürzel CM; Bibollet-Ruche F; Apps R; Leoz M; Plantier JC; Hahn BH; Finzi A; Kirchhoff F; Sauter D
    mBio; 2020 Jul; 11(4):. PubMed ID: 32665270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Vpu-Mediated CD4 and Tetherin Downregulation Functions among Major HIV-1 Group M Subtypes.
    Umviligihozo G; Cobarrubias KD; Chandrarathna S; Jin SW; Reddy N; Byakwaga H; Muzoora C; Bwana MB; Lee GQ; Hunt PW; Martin JN; Brumme CJ; Bangsberg DR; Karita E; Allen S; Hunter E; Ndung'u T; Brumme ZL; Brockman MA
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32376625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HIV-1 accessory proteins Nef and Vpu downregulate total and cell surface CD28 in CD4
    Pawlak EN; Dirk BS; Jacob RA; Johnson AL; Dikeakos JD
    Retrovirology; 2018 Jan; 15(1):6. PubMed ID: 29329537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses.
    Prévost J; Pickering S; Mumby MJ; Medjahed H; Gendron-Lepage G; Delgado GG; Dirk BS; Dikeakos JD; Stürzel CM; Sauter D; Kirchhoff F; Bibollet-Ruche F; Hahn BH; Dubé M; Kaufmann DE; Neil SJD; Finzi A; Richard J
    mBio; 2019 Jun; 10(3):. PubMed ID: 31213558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging role of the host restriction factor tetherin in viral immune sensing.
    Hotter D; Sauter D; Kirchhoff F
    J Mol Biol; 2013 Dec; 425(24):4956-64. PubMed ID: 24075872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the human immunodeficiency virus type 1 M group Vpu domains involved in antagonizing tetherin.
    Petit SJ; Blondeau C; Towers GJ
    J Gen Virol; 2011 Dec; 92(Pt 12):2937-2948. PubMed ID: 21900423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection.
    Wildum S; Schindler M; Münch J; Kirchhoff F
    J Virol; 2006 Aug; 80(16):8047-59. PubMed ID: 16873261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.